BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24569372)

  • 1. Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection.
    Kong Q; Chang LC; Takahashi K; Liu Q; Schulte DA; Lai L; Ibabao B; Lin Y; Stouffer N; Das Mukhopadhyay C; Xing X; Seyb KI; Cuny GD; Glicksman MA; Lin CL
    J Clin Invest; 2014 Mar; 124(3):1255-67. PubMed ID: 24569372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.
    Limpert AS; Cosford ND
    J Clin Invest; 2014 Mar; 124(3):964-7. PubMed ID: 24569369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
    Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
    Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of astrocyte excitatory amino acid transporter 2 alleviates central sensitization in a rat model of chronic migraine.
    Zhou X; Liang J; Wang J; Fei Z; Qin G; Zhang D; Zhou J; Chen L
    J Neurochem; 2020 Nov; 155(4):370-389. PubMed ID: 31872442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer's disease.
    Takahashi K; Kong Q; Lin Y; Stouffer N; Schulte DA; Lai L; Liu Q; Chang LC; Dominguez S; Xing X; Cuny GD; Hodgetts KJ; Glicksman MA; Lin CL
    J Exp Med; 2015 Mar; 212(3):319-32. PubMed ID: 25711212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A caspase-3-cleaved fragment of the glial glutamate transporter EAAT2 is sumoylated and targeted to promyelocytic leukemia nuclear bodies in mutant SOD1-linked amyotrophic lateral sclerosis.
    Gibb SL; Boston-Howes W; Lavina ZS; Gustincich S; Brown RH; Pasinelli P; Trotti D
    J Biol Chem; 2007 Nov; 282(44):32480-90. PubMed ID: 17823119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridazine-derivatives Enhance Structural and Functional Plasticity of Tripartite Synapse Via Activation of Local Translation in Astrocytic Processes.
    Foster JB; Zhao F; Wang X; Xu Z; Lin K; Askwith CC; Hodgetts KJ; Lin CG
    Neuroscience; 2018 Sep; 388():224-238. PubMed ID: 30056115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of translational activators of glial glutamate transporter EAAT2 through cell-based high-throughput screening: an approach to prevent excitotoxicity.
    Colton CK; Kong Q; Lai L; Zhu MX; Seyb KI; Cuny GD; Xian J; Glicksman MA; Lin CL
    J Biomol Screen; 2010 Jul; 15(6):653-62. PubMed ID: 20508255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor neuron impairment mediated by a sumoylated fragment of the glial glutamate transporter EAAT2.
    Foran E; Bogush A; Goffredo M; Roncaglia P; Gustincich S; Pasinelli P; Trotti D
    Glia; 2011 Nov; 59(11):1719-31. PubMed ID: 21769946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
    Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
    Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus.
    Kong Q; Takahashi K; Schulte D; Stouffer N; Lin Y; Lin CL
    Neurobiol Dis; 2012 Aug; 47(2):145-54. PubMed ID: 22513140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of the caspase-3 cleavage site in the astroglial glutamate transporter EAAT2 delays disease progression and extends lifespan in the SOD1-G93A mouse model of ALS.
    Rosenblum LT; Shamamandri-Markandaiah S; Ghosh B; Foran E; Lepore AC; Pasinelli P; Trotti D
    Exp Neurol; 2017 Jun; 292():145-153. PubMed ID: 28342750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
    Romera C; Hurtado O; Mallolas J; Pereira MP; Morales JR; Romera A; Serena J; Vivancos J; Nombela F; Lorenzo P; Lizasoain I; Moro MA
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1327-38. PubMed ID: 17213861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes.
    Lee SG; Su ZZ; Emdad L; Gupta P; Sarkar D; Borjabad A; Volsky DJ; Fisher PB
    J Biol Chem; 2008 May; 283(19):13116-23. PubMed ID: 18326497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis.
    Vermeiren C; Hemptinne I; Vanhoutte N; Tilleux S; Maloteaux JM; Hermans E
    J Neurochem; 2006 Feb; 96(3):719-31. PubMed ID: 16371010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumoylation of the astroglial glutamate transporter EAAT2 governs its intracellular compartmentalization.
    Foran E; Rosenblum L; Bogush A; Pasinelli P; Trotti D
    Glia; 2014 Aug; 62(8):1241-53. PubMed ID: 24753081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current approaches to enhance glutamate transporter function and expression.
    Fontana AC
    J Neurochem; 2015 Sep; 134(6):982-1007. PubMed ID: 26096891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Positive Allosteric Modulators of Glutamate Transport Have Neuroprotective Properties in an in Vitro Excitotoxic Model.
    Falcucci RM; Wertz R; Green JL; Meucci O; Salvino J; Fontana ACK
    ACS Chem Neurosci; 2019 Aug; 10(8):3437-3453. PubMed ID: 31257852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity.
    Karki P; Smith K; Johnson J; Aschner M; Lee EY
    Neurochem Res; 2015 Feb; 40(2):380-8. PubMed ID: 25064045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.
    Kim K; Lee SG; Kegelman TP; Su ZZ; Das SK; Dash R; Dasgupta S; Barral PM; Hedvat M; Diaz P; Reed JC; Stebbins JL; Pellecchia M; Sarkar D; Fisher PB
    J Cell Physiol; 2011 Oct; 226(10):2484-93. PubMed ID: 21792905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.